NCT06531603

Brief Summary

Abdominal surgeries are major surgical procedures that are performed at any teaching hospital. Pain control is major concern in the intra-operative as well as post-operative period in these patients. Optimal pain control in post-operative period is directly related to patient's recovery, shortens the patients' hospital stay and overall burden on health facilities. Inadequate pain control may affect quality of life and increases patient's morbidity and mortality. Different modalities for pain control are used in post-operative period. Opioids are mainstay of treatment in post-operative period but historically are associated with significant side effect profile like dependence, nausea, vomiting, respiratory depression, constipation and many others. Dexmedetomidine is centrally acting α-2 adrenoceptor agonist.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
64

participants targeted

Target at P50-P75 for phase_2

Timeline
Completed

Started Feb 2022

Shorter than P25 for phase_2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 20, 2022

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 20, 2023

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 20, 2023

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

July 3, 2024

Completed
29 days until next milestone

First Posted

Study publicly available on registry

August 1, 2024

Completed
Last Updated

August 1, 2024

Status Verified

July 1, 2024

Enrollment Period

11 months

First QC Date

July 3, 2024

Last Update Submit

July 29, 2024

Conditions

Keywords

BupivacaineDexmedetomidinePost operative analgesiaAbdominal surgery

Outcome Measures

Primary Outcomes (1)

  • Duration of analgesia

    Time from procedure to requirement of rescue analgesia

    Every 30 mints for 4hrs than 2hrly for 24 hrs post procedure

Secondary Outcomes (5)

  • Opioid sparing

    Total dose of nalbuhine consumption in 1st 24 hrs after procedure

  • Blood pressure

    Every 15 minutes intra operative and every 15 minutes for 24 hrs postoperatively

  • Hear rate

    Every 15 minutes intraoperative and every 15 minutes postoperatively for 24 hrs

  • Neausea

    Every 30 minutes for 4 hrs then 2hrly for 24 hrs

  • Vomiting

    Every 3 minutes for first 4 hrs then 2hrly for 24 hrs

Study Arms (2)

Bupivacaine group

EXPERIMENTAL

Patients receiving Bupivacaine plus placebo for wound infiltration after abdominal surgery for pain control.

Drug: bupivacaine wound infilteration

Bupivacaine plus Dexmedetomidine group

EXPERIMENTAL

Patients receiving Bupivacaine plus Dexmedetomidine for wound infiltration after abdominal surgery for pain control.

Drug: Bupivacaine plus dexmedetomidine wound infilteration

Interventions

drug was given at the end of surgery

Also known as: LA infiltration
Bupivacaine group

drug was given at the end of surgery

Also known as: LA + Dex infiltration
Bupivacaine plus Dexmedetomidine group

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Age limit: 18-60 years
  • Gender of patient i.e., male or female
  • Patients listed for abdominal surgeries
  • American Society of Anesthesiologists (ASA) status of I or II

You may not qualify if:

  • Patients with history of drug allergy
  • Patients who undergone any analgesia in past 24 hr
  • Patients with liver disease, kidney disease, cardiac disease, sickle cell anemia, severe preeclampsia or CNS disorder on history, clinical and laboratory assessment
  • American Society of Anesthesiologists (ASA) status III or IV
  • Patients with morbid obesity 6, Raynaud's disease Patients on adrenoceptor agonists, antagonists or narcotics before the operation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sahiwal Medical College

Sahiwal, Punjab Province, 57000, Pakistan

Location

Related Publications (13)

  • Chen J, Zhou JQ, Chen ZF, Huang Y, Jiang H. Efficacy and safety of dexmedetomidine versus propofol for the sedation of tube-retention after oral maxillofacial surgery. J Oral Maxillofac Surg. 2014 Feb;72(2):285.e1-7. doi: 10.1016/j.joms.2013.10.006. Epub 2013 Oct 25.

  • Champaneria R, Shah L, Geoghegan J, Gupta JK, Daniels JP. Analgesic effectiveness of transversus abdominis plane blocks after hysterectomy: a meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2013 Jan;166(1):1-9. doi: 10.1016/j.ejogrb.2012.09.012. Epub 2012 Oct 4.

  • Carney J, Finnerty O, Rauf J, Bergin D, Laffey JG, Mc Donnell JG. Studies on the spread of local anaesthetic solution in transversus abdominis plane blocks. Anaesthesia. 2011 Nov;66(11):1023-30. doi: 10.1111/j.1365-2044.2011.06855.x. Epub 2011 Aug 18.

  • Brogi E, Kazan R, Cyr S, Giunta F, Hemmerling TM. Transversus abdominal plane block for postoperative analgesia: a systematic review and meta-analysis of randomized-controlled trials. Can J Anaesth. 2016 Oct;63(10):1184-1196. doi: 10.1007/s12630-016-0679-x. Epub 2016 Jun 15.

  • Blaudszun G, Lysakowski C, Elia N, Tramer MR. Effect of perioperative systemic alpha2 agonists on postoperative morphine consumption and pain intensity: systematic review and meta-analysis of randomized controlled trials. Anesthesiology. 2012 Jun;116(6):1312-22. doi: 10.1097/ALN.0b013e31825681cb.

  • Bhatia N, Arora S, Jyotsna W, Kaur G. Comparison of posterior and subcostal approaches to ultrasound-guided transverse abdominis plane block for postoperative analgesia in laparoscopic cholecystectomy. J Clin Anesth. 2014 Jun;26(4):294-9. doi: 10.1016/j.jclinane.2013.11.023. Epub 2014 Jun 2.

  • Bhananker SM, Posner KL, Cheney FW, Caplan RA, Lee LA, Domino KB. Injury and liability associated with monitored anesthesia care: a closed claims analysis. Anesthesiology. 2006 Feb;104(2):228-34. doi: 10.1097/00000542-200602000-00005.

  • Ayad S, Babazade R, Elsharkawy H, Nadar V, Lokhande C, Makarova N, Khanna R, Sessler DI, Turan A. Comparison of Transversus Abdominis Plane Infiltration with Liposomal Bupivacaine versus Continuous Epidural Analgesia versus Intravenous Opioid Analgesia. PLoS One. 2016 Apr 15;11(4):e0153675. doi: 10.1371/journal.pone.0153675. eCollection 2016.

  • Ard JL Jr, Bekker AY, Doyle WK. Dexmedetomidine in awake craniotomy: a technical note. Surg Neurol. 2005 Feb;63(2):114-6; discussion 116-7. doi: 10.1016/j.surneu.2004.02.029.

  • Arain SR, Ebert TJ. The efficacy, side effects, and recovery characteristics of dexmedetomidine versus propofol when used for intraoperative sedation. Anesth Analg. 2002 Aug;95(2):461-6, table of contents. doi: 10.1097/00000539-200208000-00042.

  • Altuntas G, Akkaya OT, Ozkan D, Sayin MM, Balas S, Ozlu E. Comparison of Intraabdominal and Trocar Site Local Anaesthetic Infiltration on Postoperative Analgesia After Laparoscopic Cholecystectomy. Turk J Anaesthesiol Reanim. 2016 Dec;44(6):306-311. doi: 10.5152/TJAR.2016.75983. Epub 2016 Dec 1.

  • Abdallah FW, Chan VW, Brull R. Transversus abdominis plane block: a systematic review. Reg Anesth Pain Med. 2012 Mar-Apr;37(2):193-209. doi: 10.1097/AAP.0b013e3182429531.

  • Abdallah FW, Laffey JG, Halpern SH, Brull R. Duration of analgesic effectiveness after the posterior and lateral transversus abdominis plane block techniques for transverse lower abdominal incisions: a meta-analysis. Br J Anaesth. 2013 Nov;111(5):721-35. doi: 10.1093/bja/aet214. Epub 2013 Jun 27.

MeSH Terms

Conditions

Pain, PostoperativeBradycardiaHypotensionNauseaVomiting

Interventions

Bupivacaine

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and SymptomsArrhythmias, CardiacHeart DiseasesCardiovascular DiseasesVascular DiseasesSigns and Symptoms, Digestive

Intervention Hierarchy (Ancestors)

AnilidesAmidesOrganic ChemicalsAniline CompoundsAmines

Study Officials

  • M. Shahid, FCPS

    Sahiwal medical college sahiwal

    PRINCIPAL INVESTIGATOR
  • A. Riaz, MD

    Sahiwal medical college sahiwal

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Both patients and assessor were unaware of interventions
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

July 3, 2024

First Posted

August 1, 2024

Study Start

February 20, 2022

Primary Completion

January 20, 2023

Study Completion

April 20, 2023

Last Updated

August 1, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share

We will not share individualized data, but the outcomes of the study will be shared in the form of manuscript.

Locations